Orchestra BioMed

company

About

Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.

  • 11 - 50

Details

Last Funding Type
Series D
Last Funding Money Raised
$110M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization.

It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$110M
Orchestra BioMed has raised a total of $110M in funding over 2 rounds. Their latest funding was raised on Jan 30, 2022 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 30, 2022 Series D $110M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Orchestra BioMed is funded by 1 investors. Medtronic are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series D